Navigation Links
Synvista Therapeutics Posts Letter to Stockholders on Web Site
Date:9/17/2008

MONTVALE, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) today announced that a Letter to Stockholders is now posted to the Company's Web site http://www.synvista.com. The text is as follows:

To Our Stockholders:

The team at Synvista Therapeutics has made tremendous progress in our efforts to deliver on the promise of personalized medicine, and to redefine the treatment of cardiovascular disease in diabetics as well as the treatment of other diseases in the general population. Since my last letter in August 2007, our clinical trials with SYI-2074 for the treatment of heart disease in diabetics had inconclusive results, and we opted not to move forward with the compound's development in this indication. However, we have a robust pipeline on which we are building our business. We have:

-- Advanced our Haptoglobin (Hp) diagnostic test.

-- Developed a test for Carboxy-methyl-lysine (CML), a biomarker of

advanced glycation end product (A.G.E.) formation, which is believed to

play a part in cardiovascular disease.

-- Initiated two Phase 2 trials with alagebrium for chronic heart failure.

-- Advanced the development of a topical formulation for the use of

SYI-2074 in the treatment of psoriasis.

-- Chosen a lead Glutathione peroxidase mimetic generated in a discovery

collaboration with Provid Pharmaceuticals, that is now being evaluated

for its ability to restore reverse cholesterol transport and treat

atherosclerosis.

-- Strengthened our management team and board of directors with

appointments in research, development and marketin
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
2. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
3. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
4. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
5. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
6. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
7. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
8. Synvista Therapeutics to be Featured on Wallst.net
9. Synvista Therapeutics to Present at the BIO InvestorForum 2007
10. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Worcester, Mass. (PRWEB) , ... July 06, 2015 ... ... by Worcester Polytechnic Institute (WPI), offers new insights into how virulent fungi adapt ... block their spread, and how that battle leaves them temporarily weakened. These insights ...
(Date:7/6/2015)... 29, 2015 Research ... addition of the "Biotechnology for the Non-Biotechnologist" ... for the Non-Biotechnologist, ideal for non-Scientists and Scientists ... and potential of biotechnology. Ideal for ... theory, principles, techniques, and potential of biotechnology ...
(Date:7/3/2015)... ... July 03, 2015 , ... DryLet, ... as animal waste reduction, bioremediation, wastewater treatment, aquaculture and grease, fat and ... that it will be showcasing, ManureMagic™, its industry-leading product for animal waste ...
(Date:7/3/2015)... July 3, 2015 ... Open Innovation in Science", som finner sted ... sendes på nett, på  http://www.openinnovationinscience.at , og ... De to største utfordringene innen ... undersøke nye forskningsspørsmål og kompleksiteten av nåværende ...
Breaking Biology Technology:Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4DryLet to Highlight Benefits of Patented ManureMagic™ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3
... April 1, 2011 Optimer Pharmaceuticals, Inc. (NASDAQ: ... Compensation Committee of its Board of Directors approved the grant ... shares of common stock to 7 new employees. ... an exercise price per share equal to $11.83, the fair ...
... principles of quantum mechanics apply to biological systems? Until ... Physics Department (Faculty of Chemistry), both biologists and physicists ... like apples and oranges. But research he conducted together ... Science , definitively shows that a biological molecule ...
... Technology (NIST) have developed a way to measure the wear ... structures in situ and as it,s happening. Their technique can ... most precise and delicate nanoscale measurements done with atomic force ... of a surface with a ruler that,s crumbling away as ...
Cached Biology Technology:Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Biological molecules select their spin 2Getting the point: Real-time monitoring of atomic-microscope probes adjusts for wear 2
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... the addition of the "Next Generation Biometrics Market ... to 2020" report to their offering. ... $24.4 Billion by 2020, at a CAGR of 17.9% ... is the leading application for the market. Safran ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical ... use solutions, headquartered in Springville, Utah , ... California corporation with locations in Santa ... Rica ). This acquisition will incorporate MedConx,s ... ATL Technology,s existing facility in Costa Rica ...
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... expedition in Australia and New Zealand to find the rare ... researchers to confirm new developmental similarities between fish and mammals. ... same genetic process for forming skeletal gill covers that lizards ... the University of Chicago and the University of Cambridge found. ...
... an essential nutrientironis scarce, a marine bacterium that launches the ... It recycles iron. By day, it uses iron in ... appears to reuse the same iron in different enzymes to ... watsonii , is one of the few marine microbes that ...
... NY, January 10, 2011The mega-mergers of 2009 did not continue ... had a price tag of more than $40 billion, only ... an evaluation of reported deals conducted by Genetic Engineering & ... takeover for the year, sanofi-aventis, move to buy Genzyme, is ...
Cached Biology News:Hard-to-find fish reveals shared developmental toolbox of evolution 2Hard-to-find fish reveals shared developmental toolbox of evolution 3'Hot-bunking' bacterium recycles iron to boost ocean metabolism 2'Hot-bunking' bacterium recycles iron to boost ocean metabolism 3GEN reports on biotech acquisition deals in 2010 that topped $1 billion 2
... This kit allows for quick and reproducible ... plate. The system is more reproducible than regular ... the protein A/G agarose without disrupting the agarose ... Catch and Release is reversible, and elution of ...
... Oligo Microarray Kit (V2), 2 x ... characterize expression of many thousands of ... during important biological processes. Each microarray ... known ORFs from the S288C strain ...
... Successful biomarker discovery projects require screening ... to distinguish clinically relevant data from ... Data Manager is now available to ... tracking and data flood inherent to ...
... Immunoprecipitation kit allows a rapid and ... active FLAG-tagged protein. The immunoprecipitation is ... is a highly specific monoclonal antibody ... use of affinity resin allows an ...
Biology Products: